Mirion Technologies, Inc. (MIR)
About Mirion Technologies, Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $925.4M
- Net income
- $28.8M
- Total assets
- $3.6B
- Market cap
- $4.2B
- Gross margin
- 47.4%
- Operating margin
- 5.6%
- Net margin
- 3.2%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $925.4M
- Cost of revenue
- $486.8M
- Gross profit
- $438.6M
- Operating expenses
- $387.1M
- Operating income
- $51.5M
- Income tax
- $2.9M
- Net income
- $29.8M
- EPS (basic)
- $0.13
- EPS (diluted)
- $0.11
Balance sheet
- Total assets
- $3.6B
- Current assets
- $893.7M
- Total liabilities
- $1.7B
- Current liabilities
- $316.1M
- Shareholders’ equity
- $1.9B
Cash flow
- Operating cash flow
- $143.3M
- Investing cash flow
- -$694.6M
- Financing cash flow
- $775.9M
- Net cash flow
- $224.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $4.2B
- P/E ratio
- 150.4
- EPS (diluted)
- $0.11
- Shares outstanding
- 252.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 20, 2020
Mirion Technologies, Inc. (MIR) Stock Price
- Profitable — net income of $28.8M in FY2025.
- Gross margin of 47.4%, net margin 3.2%.
- Trading 44% below its 52-week high.
- Valued at a price-to-earnings (P/E) ratio of 150.4.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Mirion Technologies, Inc..
Write a review
News about Mirion Technologies, Inc.
News & sentiment via Polygon.io
Mirion Technologies, Inc.: frequently asked questions
Is Mirion Technologies, Inc. an American company?
Mirion Technologies, Inc. is a US-based company headquartered in Atlanta, Georgia, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Mirion Technologies, Inc. headquartered?
Mirion Technologies, Inc. is headquartered in Atlanta, Georgia, United States.
Is Mirion Technologies, Inc. publicly traded?
Yes — Mirion Technologies, Inc. is a publicly traded company. Its stock trades under the ticker symbol MIR on the NYSE.
What does Mirion Technologies, Inc. do?
Mirion Technologies, Inc. is an American Medical Devices company in the Health & Beauty sector.
